Skip to main content
TipRanks
Go Ultimate75% OFF

Allogene Therapeutics (ALLO) Q4 2021 Earnings Report

1,853 Followers

ALLO Q4 2021 EPS Results

Actual EPS
-$0.54
Consensus EPS
-$0.60
Beat/Miss
Beat by +$0.06
One Year Ago EPS
-$0.53

ALLO Q4 2021 Revenue Results

Actual Revenue
$51.00K
Expected Revenue
-$8,000
Beat/Miss
Beat by +$59.00K
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2021
Date
02/23/2022
Time
After Close
Conference Call
Wednesday, February 23, 2022
ALLO Upcoming Earnings

Allogene Therapeutics's next earnings date is estimated for March 18, 2027, based on past reporting schedules.

Q4 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

ALLO Earnings History

ALLO earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 18, 20272026 (Q4)-0.16--0.17――
Nov 05, 20262026 (Q3)-0.15-0.15-0.1921.05% (+0.04)
Aug 12, 20262026 (Q2)-0.17-0.13-0.2343.48% (+0.10)
May 13, 20262026 (Q1)-0.19-0.18-0.2835.71% (+0.10)
Mar 12, 20262025 (Q4)-0.23-0.17-0.2839.29% (+0.11)
Nov 06, 20252025 (Q3)-0.22-0.19-0.3240.63% (+0.13)
Aug 13, 20252025 (Q2)-0.27-0.23-0.3534.29% (+0.12)
May 13, 20252025 (Q1)-0.29-0.28-0.3826.32% (+0.10)
Mar 13, 20252024 (Q4)-0.33-0.28-0.5145.10% (+0.23)
Nov 07, 20242024 (Q3)-0.33-0.32-0.3713.51% (+0.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed